Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 19, 2013
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 19, 2013
Lead Product(s) : Cevimeline Hydrochloride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable